Subscribe to Get Prostate Cancer News

Hot SHEET 2020

Made possible by charitable contributions from


 - Thank You!


Our monthly newsletter, the Hot SHEET, highlights the latest in treatment strategies as well as emerging treatments. The Hot SHEET is distributed free at chapter support group meetings, and is available in PDF on the Us TOO web site.

Subscribe to get the Hot SHEET (and other prostate cancer news and information) for free via email from Us TOO at

Hot SHEET Personal Subscriptions Now Available

If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office. Download and print a subscription order form or order online.

  • Pembrolizumab Shows Limited Activity Against Prostate Cancer
  • When the Going Gets Tough… How to Help Yourself or a Friend
  • Olaparib in Patients with Metastatic Castrate-Resistant Prostate Cancer
  • Impact of Age at Diagnosis of De Novo Metastatic Prostate Cancer
  • Clinical Utility of a Genomic Classifier In Men Undergoing RP
  • Doc Moyad's No Bogus Science Column: "2020—The Year of the Statin & Elvis?!"
  • Variation in the Prescription of Androgen Deprivation Therapy
  • The Role of Hypofractionated Radiotherapy for Localized PCa
  • New Tools May ID Intermediate-Risk PCa Patients Suitable for AS
  • Index of Articles Published in 2019 Us TOO Hot SHEETs
  • Chemo Triumphs in Second Line Metastatic Prostate Cancer
  • Salvage RT First Found Superior for Post-RP PSA Failure
  • Tailored Pelvic PT May Curb Post-RP Incontinence & Pain
  • AS, RP, EBRT or Brachytherapy With or Without ADT
  • Doc Moyad's No Bogus Science Column: "Resistance Training!?"
  • Extended Pelvic Lymph Node Dissection & PCa Outcomes
  • More Veggies No Help in AS
  • Outcomes of Hypofractionated/ Conventionally Fractionated RT
  • Anterior-Dominant PCa Harder to Detect Than Other Locations
  • Impact of MRI & Targeted Biop-sies on Eligibility for Surveillance
  • Implications of Germline Genetic Testing in Prostate Cancer
  • Tumor-Associated Release of Prostatic Cells After Biopsies
  • Lower Out-of-Pocket Costs for Robotic Cancer Surgery
  • More Radium-223 in mCRPC Means More Toxicity
  • Stalling ADT Use in Recurrent PCa
  • Validation of Gallium-68 PSMA PET/CT for Primary PCa Staging
  • Long-Term Follow-Up in Low-Dose-Rate Brachytherapy for PCa
  • Doc Moyad's No Bogus Science: "Lorcaserin Bites the Dust!?"
  • Apalutamide & Overall Survival in Non-Metastatic CRPC
  • Pembrolizumab for Treating Refractory Metastatic CRPC
  • PET Spots Prostate Cancer Metastases Missed on CT, MRI
  • Modest Survival Gains Shown in Newly Diagnosed Metastatic PCa
  • Long-Term Outcomes in Gleason Grades 2 & 3 PCa with AS
  • Guest Column: Staying Sexually Active After PCa Treatment
  • Earlier Cabazitaxel Use in mCRPC